Neurogene Offers Access to Genetic Testing to Patients Suspected of Having a Lysosomal Storage Disease
Invitae Corporation (NVTA)
Last invitae corporation earnings: 2/19 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.invitae.com/investor-relations/default.aspx
Company Research
Source: Business Wire
Neurogene joining with Invitae to reduce barriers to genetic testing for more than 50 lysosomal storage diseasesInitiative is designed to identify the many patients with AGU that are currently misdiagnosed or undiagnosed NEW YORK--(BUSINESS WIRE)--Neurogene Inc., a company founded with a mission to bring life-changing medicines to patients and families affected by rare neurological diseases, today announced it has become the founding sponsor of a new program called “Detect Lysosomal Storage Diseases (LSDs)” from Invitae, a leading medical genetics company. With support from Neurogene for this program, Invitae offers genetic testing and counseling at no charge to patients suspected of having a lysosomal storage disease, or LSD.“As Neurogene works to find an effective gene therapy for patients and their families living with an LSD called AGU, we are also taking critical steps to learn more about the disease and identify patients,” said Rachel McMinn, Ph.D., Neurogene’s Founder and Ch
Show less
Read more
Impact Snapshot
Event Time:
NVTA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVTA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVTA alerts
High impacting Invitae Corporation news events
Weekly update
A roundup of the hottest topics
NVTA
News
- Invitae gets court approval for five-month bankruptcy sale [Reuters]Reuters
- Invitae gets court approval for five-month bankruptcy sale [Yahoo! Finance]Yahoo! Finance
- Genetic Testing Firm Invitae, Backed by SoftBank and Cathie Wood, Files for Chapter 11 [Yahoo! Finance]Yahoo! Finance
- Invitae files for Chapter 11 bankruptcy to address huge debt load [Seeking Alpha]Seeking Alpha
- Genetic test maker Invitae files for bankruptcy protection in US [Reuters]Reuters
NVTA
Earnings
- 11/8/23 - Miss
NVTA
Sec Filings
- 2/14/24 - Form 8-K
- 2/13/24 - Form SC
- 2/13/24 - Form SC
- NVTA's page on the SEC website